<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>The kinetics of non-radioactive <z:chebi fb="0" ids="16990">bilirubin</z:chebi> were investigated in 100 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> non-haemolytic <z:e sem="disease" ids="C0268306" disease_type="Disease or Syndrome" abbrv="">unconjugated hyperbilirubinaemia</z:e> and in nine <z:mpath ids='MPATH_458'>normal</z:mpath> volunteers </plain></SENT>
<SENT sid="2" pm="."><plain>2 </plain></SENT>
<SENT sid="3" pm="."><plain>The patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> were divided on the basis of a two-compartment model into two distinct groups: group 1 (74 patients) with decreased hepatic uptake and conjugation of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> and a <z:chebi fb="0" ids="16990">bilirubin</z:chebi> turnover rate within the <z:mpath ids='MPATH_458'>normal</z:mpath> range, and group 2 (26 patients) having <z:mpath ids='MPATH_458'>normal</z:mpath> uptake, impaired conjugation and <z:hpo ids='HP_0003573'>increased bilirubin</z:hpo> turnover rate </plain></SENT>
<SENT sid="4" pm="."><plain>3 </plain></SENT>
<SENT sid="5" pm="."><plain>On the basis of these findings, studies were made of early pigment production in four patients of group 1, in six patients of group 2 and in four of the <z:mpath ids='MPATH_458'>normal</z:mpath> volunteers, with [<z:chebi fb="32" ids="36927">14C</z:chebi>]glycine and delta-[3H]aminolaevulinic acid </plain></SENT>
<SENT sid="6" pm="."><plain>4 </plain></SENT>
<SENT sid="7" pm="."><plain>After receiving injections of labelled haem precursors, the four patients in group 1 had a <z:mpath ids='MPATH_458'>normal</z:mpath> rate of incorporation of both tracers, whereas abnormalities in incorporation were found in group 2 </plain></SENT>
<SENT sid="8" pm="."><plain>Four patients showed an increase of the first component of the early peak of [<z:chebi fb="32" ids="36927">14C</z:chebi>]<z:chebi fb="0" ids="16990">bilirubin</z:chebi> as well as of the early peak of [3H]<z:chebi fb="0" ids="16990">bilirubin</z:chebi>, suggesting an increased turnover of hepatic haem </plain></SENT>
<SENT sid="9" pm="."><plain>Two patients showed an increased incorporation of [<z:chebi fb="32" ids="36927">14C</z:chebi>]glycine characterized by the fusion of the two early peaks, whereas the incorporation of the delta-[3H]aminolaevulinic acid was <z:mpath ids='MPATH_458'>normal</z:mpath>, indicating the presence of a primary <z:e sem="disease" ids="C0221021" disease_type="Disease or Syndrome" abbrv="">shunt hyperbilirubinaemia</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>5 </plain></SENT>
<SENT sid="11" pm="."><plain>The results confirm that <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> condition with respect to <z:chebi fb="0" ids="16990">bilirubin</z:chebi> turnover rate </plain></SENT>
<SENT sid="12" pm="."><plain>The population of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> with <z:hpo ids='HP_0003573'>increased bilirubin</z:hpo> turnover rate comprises not only patients with an increased haem erythroid turnover, but also patients with increased metabolism of non-erythroid <z:chebi fb="0" ids="35137">haem protein</z:chebi> in the liver </plain></SENT>
</text></document>